Close Menu
  • Home
  • Finance News
  • Personal Finance
  • Investing
  • Cards
    • Credit Cards
    • Debit
  • Insurance
  • Loans
  • Mortgage
  • More
    • Save Money
    • Banking
    • Taxes
    • Crime
What's Hot

Bessent says Powell doesn’t need to resign but should conduct internal review

July 22, 2025

Creeping controls on the movement of capital will stunt global growth

July 22, 2025

How the One Big Beautiful Bill Act Affects Federal Employees and Retirees

July 22, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
Smart SpendingSmart Spending
Subscribe
  • Home
  • Finance News
  • Personal Finance
  • Investing
  • Cards
    • Credit Cards
    • Debit
  • Insurance
  • Loans
  • Mortgage
  • More
    • Save Money
    • Banking
    • Taxes
    • Crime
Smart SpendingSmart Spending
Home»Finance News»Stocks making the biggest moves midday: XYZ, SEDG, CLF, VZ
Finance News

Stocks making the biggest moves midday: XYZ, SEDG, CLF, VZ

July 22, 2025No Comments3 Mins Read
Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
Stocks making the biggest moves midday: XYZ, SEDG, CLF, VZ
Share
Facebook Twitter LinkedIn Pinterest Email

Check out the companies making the biggest moves midday: Bruker — The lab instrument and tools maker shed 12% after the company issued weaker-than-expected guidance for the second quarter. The company expects to earn between 32 cents and 34 cents per share on revenue ranging from $795 million to $798 million. Analysts polled by FactSet expected a profit of 42 cents per share on revenue of $813.3 million. Block — The fintech stock surged 8% as it prepares to officially join the S & P 500 before the opening of trading on July 23. Block will replace Hess, which has been acquired by Chevron. Arrowhead Pharmaceuticals — The biotech company fell nearly 12%, adding to its steep decline from the previous session. Shares slid 11.1%, following those of Sarepta Therapeutics. Sarepta Therapeutics — The biotech stock tumbled 7% after the U.S. Food and Drug Administration announced following Friday’s close that it was pulling its support for Elevidys, a gene therapy developed by Sarepta used to treat Duchenne muscular dystrophy, after another patient death. Shops such as Leerink Partners, Mizuho and Needham soon downgraded the stock. Alkermes — The biopharma company lost 9% after it announced Phase 2 trial results for its alixorexton drug, which aims to treat patients with narcolepsy Type 1. EQT Corporation — Shares of the largest natural gas producer in the U.S. fell 8% after CEO Toby Rice told the Financial Times that China will win the artificial intelligence race unless Congress streamlines permitting for projects. Pinterest — Shares of the social media company jumped more than 2% after Morgan Stanley analyst Brian Nowak upgraded the stock to overweight from equal weight. Nowak highlighted Pinterest’s attractive valuation along with “GPU enabled investments and budding engagement and monetization improvements” as the key reasons for his new rating. SolarEdge — The solar technology manufacturer’s stock jumped 8% after analysts at Susquehanna increased their price target for the company to $26. But solar stocks face big headwinds as President Donald Trump moves to end federal support for the sector. Dollar Tree — Shares added 2.2% upon an upgrade to overweight from equal weight at Barclays. Analyst Seth Sigman said he expects a “cleaner growth story” ahead. Cleveland-Cliffs — The steel manufacturer gained 13% after the company said it expected to spend less money than anticipated on capital expenditures and administrative expenses for the full year. That overshadowed a larger-than-expected loss for the second quarter. Verizon — The telecommunications stock rose 5% after posting second-quarter earnings of $1.22 per share on revenue of $34.5 billion. Analysts were expecting earnings of $1.18 billion on $33.74 billion in revenue, according to LSEG. Invesco — Shares added 1% after TD Cowen upgraded the investment management firm to a buy rating from hold. Analyst Bill Katz called Invesco’s Friday announcement that it was requesting to migrate its QQQ exchange-traded fund to an open-end fund structure from a unit investment trust a “game changing event.” — CNBC’S Spencer Kimball contributed reporting.

See also  How To Get Organized And Save Money In 2025

Source link

Biggest CLF Making midday Moves SEDG stocks XYZ
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Previous ArticleTreasury CDFI Fund director resigns
Next Article With new ownership in place, WealthONE aims to become Canada’s next major alt-A bank

Related Posts

Bessent says Powell doesn’t need to resign but should conduct internal review

July 22, 2025

Federal student loan changes making you eye private lenders? Here are 7 with federal loan-like perks

July 22, 2025

ACA health plan enrollees could face ‘subsidy cliff’ in 2026

July 22, 2025
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Citigroup (C) earnings Q4 2024 beat

January 15, 2025

Stocks making the biggest moves premarket: NFLX, AXP, CVX, SRPT

July 19, 2025

Fed keeps interest rates unchanged as it weighs inflation risks from tariffs

June 22, 2025
Ads Banner

Subscribe to Updates

Subscribe to Get the Latest Financial Tips and Insights Delivered to Your Inbox!

Stay informed with our finance blog! Get expert insights, money management tips, investment strategies, and the latest financial news to help you make smart financial decisions.

We're social. Connect with us:

Facebook X (Twitter) Instagram YouTube
Top Insights

Bessent says Powell doesn’t need to resign but should conduct internal review

July 22, 2025

Creeping controls on the movement of capital will stunt global growth

July 22, 2025

How the One Big Beautiful Bill Act Affects Federal Employees and Retirees

July 22, 2025
Get Informed

Subscribe to Updates

Subscribe to Get the Latest Financial Tips and Insights Delivered to Your Inbox!

© 2025 Smartspending.ai - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.